BioDelivery Sciences' Prochlorperazine Oral Buccal Tablet Is Bucked Off Course
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA "not approvable" letter for Emezine is due to the pharmacokinetic profile of its oral buccal tablet formulation.